best performing stocks in the 20b cap 2012 to 2014

Alnylam Pharmaceuticals (ALNY) had the highest return between 2012 and 2014 by a US stock with a market cap of $20B+, returning 1,064.5%.

ASSETYEARS% RETURN
Alnylam Pharmaceuticals (ALNY)
2012-2014
1,064.47%
Genmab A-S (GMAB)
2012-2014
796.02%
Cheniere Energy (LNG)
2012-2014
691.9%
Tesla (TSLA)
2012-2014
668.53%
Regeneron Pharmaceuticals (REGN)
2012-2014
625.98%
Delta Air Lines (DAL)
2012-2014
505.68%
Illumina (ILMN)
2012-2014
495.42%
DexCom (DXCM)
2012-2014
478.26%
Micron Technology (MU)
2012-2014
427.26%
Axon Enterprise (AXON)
2012-2014
405.34%
Corpay (CPAY)
2012-2014
396.2%
Insmed (INSM)
2012-2014
395.83%
Southwest Airlines (LUV)
2012-2014
395.1%
Netflix (NFLX)
2012-2014
386.07%
Incyte (INCY)
2012-2014
385.78%
NXP Semiconductors (NXPI)
2012-2014
384.16%
Constellation Brands Inc Class A (STZ)
2012-2014
368.37%
Gilead Sciences (GILD)
2012-2014
354.7%
Seagate Technology (STX)
2012-2014
343.19%
HCA Healthcare (HCA)
2012-2014
316.24%
Western Digital (WDC)
2012-2014
269.1%
Broadcom (AVGO)
2012-2014
260.4%
Vertex Pharmaceuticals (VRTX)
2012-2014
251.27%
United Airlines (UAL)
2012-2014
247.84%
Monolithic Power Systems (MPWR)
2012-2014
240.46%